Unusual Whales has partnered with @Temaetfs & their $HRTS, the GLP-1 ETF, for earnings of Eli Lilly, $LLY, & Novo Nordisk, $NOVO. $NOVO's expected revenue is $10.8 billion, previous $10.01 billion. See $HRTS ETF for exposure to weight loss drug stocks